238 related articles for article (PubMed ID: 2972939)
21. U50,488H differentially antagonizes the bladder effects of mu agonists at spinal sites.
Sheldon RJ; Nunan L; Porreca F
Eur J Pharmacol; 1988 Feb; 146(2-3):229-35. PubMed ID: 2836207
[TBL] [Abstract][Full Text] [Related]
22. The effects of protection by D-Pen2-D-Pen5-enkephalin or D-Ala2-NMePhe4-Gly-ol-enkephalin against beta-chlornaltrexamine in the spinal cord on the antinociception induced by beta-endorphin administered intracerebroventricularly in the mouse.
Suh HW; Lim JS; Song DK; Kim YH; Tseng LF
Neuropeptides; 1994 Aug; 27(2):143-9. PubMed ID: 7991069
[TBL] [Abstract][Full Text] [Related]
23. Supraspinal administration of opioids with selectivity for mu-, delta- and kappa-opioid receptors produces analgesia in amphibians.
Stevens CW; Rothe KS
Eur J Pharmacol; 1997 Jul; 331(1):15-21. PubMed ID: 9274924
[TBL] [Abstract][Full Text] [Related]
24. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
Sánchez-Blázquez P; Garzón J
Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
[TBL] [Abstract][Full Text] [Related]
26. Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse.
Tseng LF; Collins KA; Kampine JP
Eur J Pharmacol; 1994 Jun; 258(1-2):R1-3. PubMed ID: 7925585
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
28. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice.
Suh HH; Tseng LF
Pharmacol Biochem Behav; 1990 Apr; 35(4):807-13. PubMed ID: 2161107
[TBL] [Abstract][Full Text] [Related]
29. Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria.
Mantelli L; Amerini S; Rubino A; Ledda F
Eur J Pharmacol; 1990 May; 180(2-3):325-30. PubMed ID: 1973118
[TBL] [Abstract][Full Text] [Related]
30. Dexamethasone-induced selective inhibition of the central mu opioid receptor: functional in vivo and in vitro evidence in rodents.
Pieretti S; Di Giannuario A; Domenici MR; Sagratella S; Capasso A; Sorrentino L; Loizzo A
Br J Pharmacol; 1994 Dec; 113(4):1416-22. PubMed ID: 7889299
[TBL] [Abstract][Full Text] [Related]
31. Intracerebroventricular N-ethylmaleimide differentially reduces supraspinal opioid analgesia in mice.
Sánchez-Blázquez P; Ulibarri I; Garzón J
Eur J Pharmacol; 1989 Jul; 166(2):193-200. PubMed ID: 2676563
[TBL] [Abstract][Full Text] [Related]
32. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
Jiang Q; Sheldon RJ; Porreca F
J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010
[TBL] [Abstract][Full Text] [Related]
33. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
34. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
35. Further characterization of alpha N-acetyl beta-endorphin-(1-31) regulatory activity, I: Effect on opioid- and alpha 2-mediated supraspinal antinociception in mice.
Sánchez-Blázquez P; Garzón J
Life Sci; 1992; 50(26):2083-97. PubMed ID: 1318989
[TBL] [Abstract][Full Text] [Related]
36. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
[TBL] [Abstract][Full Text] [Related]
37. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
38. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
Fang FG; Fields HL; Lee NM
J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
[TBL] [Abstract][Full Text] [Related]
39. The tail-flick inhibition induced by beta-endorphin administered intrathecally is mediated by activation of kappa- and mu-opioid receptors in the mouse.
Tseng LF; Collins KA
Eur J Pharmacol; 1992 Apr; 214(1):59-65. PubMed ID: 1316280
[TBL] [Abstract][Full Text] [Related]
40. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
